Fennec Pharmaceuticals In... (FENC)

AI Score

Unlock

6.78

-0.24 (-3.42%)

At close: Mar 03, 2025, 3:59 PM

6.77

-0.15%

After-hours: Mar 03, 2025, 04:00 PM EST

Fennec Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00
Net Income	-16.05M	-23.71M	-17.35M	-18.11M	-12.78M	-9.89M	-7.05M	-2.79M	-659K	-2.18M	1.84M	-5.16M	4.68M	-7.82M	-3.01M	-13.6M	-13.36M	-19.1M	-19.25M	-8.74M	-6.15M	-3.72M	-2.45M	-1.6M
Depreciation & Amortization	n/a	132K	14K	402K	64K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	164K	192K	2.43M	3.06M	2.52M	1.61M	123.76K	55.23K	52.01K
Stock-Based Compensation	5.35M	4.22M	4.01M	2.88M	3.08M	1.82M	1.52M	615K	97K	627K	87K	326K	250K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	819.83K	1.61M	-138K	-722K	-11K	-45K	402K	64K	-52K	24K	-365K	n/a	n/a	n/a	n/a	119K	-2.46M	2.12M	1M	605.48K	n/a	n/a	n/a	351.85K
Other Non-Cash Items	326K	334K	307K	486K	481K	105K	875K	40K	-1.24M	-270K	-3.78M	1.56M	-8.08M	5.78M	213K	2.49M	2.32M	2.61M	2.93M	-376.3K	-313.29K	n/a	0.00	-30.39K
Deferred Income Tax	n/a	n/a	-14K	-402K	-64K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.53M	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-6.78M	1.1M	-932K	-763K	569K	132K	1.01M	10K	-63K	120K	-365K	280K	-81K	116K	-1.89M	134K	-2.46M	2.12M	1M	605.48K	-578.33K	366.82K	-289.04K	351.85K
Operating Cash Flow	-17.14M	-18.06M	-14.22M	-15.6M	-9.06M	-7.83M	-3.64M	-2.12M	-1.86M	-1.7M	-2.21M	-2.99M	-3.23M	-1.93M	-4.69M	-10.81M	-13.3M	-13.47M	-12.26M	-5.99M	-5.43M	-3.23M	-2.69M	-1.22M
Capital Expenditures	2.75	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-15K	-73K	-5K	-102K	-155.12K	-69.79K	-298.72K	-331.6K	-32.32K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.44M	-7.11M	n/a	-5.37M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.18M	2.26M	n/a	6.04M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	24K	-15K	-2K	1.17M	22K	193.15K	-861.93K	-130.1K	8.4K	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	24K	-15K	-75K	1.17M	-1.25M	-7.07M	5.11M	-5.8M	-323.2K	-32.32K
Debt Repayment	5M	19.93M	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-40K	28K	-59K	n/a	1.3M	1.93M	-32.97K	-24.29K
Common Stock Repurchased	-78K	-194K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.64M	797K	-22K	322K	-71K	2.35M	594K	108K	497K	161K	n/a	n/a	n/a	n/a	n/a	7K	n/a	-70K	-141K	24.56M	-377.3K	-0.41	n/a	0.09
Financial Cash Flow	6.64M	20.73M	4.98M	32.29M	-71K	2.35M	27.98M	5.11M	497K	2.34M	1.57M	n/a	2.57M	7.19M	n/a	7K	23.88M	6.05M	7.96M	24.56M	2.24M	-33.34K	12.25M	1.28M
Net Cash Flow	-10.51M	2.67M	-9.24M	16.69M	-9.13M	-5.48M	24.33M	2.98M	-1.36M	644K	-640K	-2.99M	-650K	5.26M	-4.66M	-10.81M	10.5M	-6.25M	-5.56M	11.5M	1.92M	-9.06M	9.24M	24.33K
Free Cash Flow	-17.14M	-18.06M	-14.22M	-15.6M	-9.06M	-7.83M	-3.64M	-2.12M	-1.86M	-1.7M	-2.21M	-2.99M	-3.23M	-1.93M	-4.69M	-10.82M	-13.38M	-13.48M	-12.36M	-6.14M	-5.5M	-3.53M	-3.02M	-1.26M